Influencing factors of virus duration and virus clearance in COVID-19 patients in Shenzhen: A retrospective study.

Lina Zhang, Xiaoàn Yang, Xuan Li, Yifan Jia, Fang Huang, Ka Zhang, Qing‐Yu HeResearch Square 2020 · DOI

Abstract

Background: This study aimed to analyze the factors influencing virus duration and clearance in COVID-19 patients in Shenzhen, China, to improve clinical management strategies. Methods: Clinical and laboratory data from 201 COVID-19 inpatients at the Third People's Hospital of Shenzhen (January–March 2020) were retrospectively analyzed. Virus clearance was defined as two consecutive negative RT-PCR results. Results: The median virus duration was 17 days. Early treatment timing was associated with faster clearance, while glucocorticoid usage and age over 60 years were identified as detrimental factors. Conclusion: Early detection and treatment are critical. Glucocorticoid use should be restricted as it may delay viral clearance.

Introduction

In the early stages of the COVID-19 pandemic, understanding the timeline of viral shedding was critical for determining isolation periods and discharge criteria. While much research focused on mortality and acute respiratory distress, this study investigates the "natural history" of the virus within the host. By identifying the clinical characteristics and interventions that correlate with "long shedders"—patients who take significantly longer to achieve viral clearance—clinicians can better manage resources and patient expectations.

Methods

Researchers conducted a retrospective cohort study of 201 patients at The Third People's Hospital of Shenzhen.

  • Definition of Clearance: Two consecutive negative RT-PCR results from nasopharyngeal swabs, taken at least 24 hours apart.
  • Statistical Approach: Univariate analysis identified potential factors, followed by multivariate logistic regression to isolate independent predictors, controlling for confounding variables such as disease severity.

Results

The study population included 112 men (55.7%) and 89 women (44.3%). Patients were categorized into non-severe (n=131) and severe (n=70) groups. Severe patients exhibited a significantly longer median viral duration (20 days) compared to non-severe patients (15 days).

Clinical characteristics and treatment outcomes of COVID-19 patients.

Key Findings on Viral Clearance

The overall median time to viral clearance was 17 days. The study tracked clearance milestones over a six-week period, revealing a stark contrast between patient groups as time progressed. By the end of the second week, 45% of non-severe patients had cleared the virus, compared to only 20% of severe patients.

Cumulative virus clearance rates over a six-week period.

Multivariate analysis highlighted three primary factors influencing these timelines:

  1. Treatment Timing: Patients who began treatment within seven days of symptom onset cleared the virus significantly faster.
  2. Glucocorticoid Usage: Often used to suppress inflammatory "cytokine storms," steroids were found to be a significant disadvantageous factor. In the multivariate model, steroid use was associated with an 11.273-fold increase in the odds of failing to clear the virus within four weeks.
  3. Age: Patients over 60 were nearly 8 times more likely (OR = 7.890) to remain positive at the four-week mark, likely due to immunosenescence.

Discussion

The Steroid Paradox

While glucocorticoids are vital for managing severe inflammation, this data suggests they may inadvertently allow the virus to persist by dampening the initial immune response. This finding suggests that steroid use should be carefully restricted and perhaps reserved for specific inflammatory windows rather than used broadly.

The "Golden Window"

The correlation between early treatment and faster clearance reinforces the public health mantra of "early detection, early treatment." Initiating care within the first week of symptoms appears to be a decisive factor in reducing the duration of viral shedding.

Conclusion

This retrospective study emphasizes that treatment timing is a primary driver of COVID-19 viral clearance. To optimize patient outcomes and public health safety, early intervention strategies are paramount. Furthermore, clinicians should exercise caution with glucocorticoid therapy, as it may prolong the period during which a patient remains infectious. Older age remains a significant hurdle for rapid viral resolution, necessitating closer monitoring for patients over 60.

Summary updated

Abstract

<title>Abstract</title> Abstract Background. We aimed to analyze the influencing factors of virus duration and virus clearance in coronavirus disease 2019 (COVID-19) in Shenzhen, China, and to provide our experience in the treatment and management of COVID-19. Methods. The clinical data and laboratory test results of COVID-19 inpatients admitted to the Third People's Hospital of Shenzhen, Guangdong Province from January 2020 to March 2020 were retrospectively collected. In COVID-19 rehabilitation patients, two consecutive negative RT-PCR results on nasopharyngeal swabs were defined as virus clearance. The time from onset of the disease to virus clearance was defined as the virus duration. We analyzed the virus clearance rate at different time points and the impact of clinical features and treatments on virus clearance. Results. A total of 201 patients with COVID-19, including 89 women (44.3%) and 112 men (55.7%), were included in our study. According to the severity of the disease, the patients were divided into no severe patients and severe patients. The overall median virus duration for all patients was 17 days. The overall virus clearance rates within 1, 2, 3, 4, 5, and 6 weeks after onset were 1.5%, 36.6%, 73.4%, 90.2%, 97.3%, and 100%, respectively. A multiple linear regression model was performed to analyze the factors influencing virus clearanc.The factors influencing virus clearance within 2 weeks were treatment timing and glucocorticoid usage. The influencing factors for virus clearance within 4 weeks were treatment timing, glucocorticoid usage and age. Conclusion. Treatment timing was related to virus clearance. The earlier the treatment was initiated, the faster the virus clearance. For COVID-19 patients, early detection and early treatment strategies should be adopted. Glucocorticoid usage may be detrimental to virus clearance and should be more restricted. Age &gt; 60 years may also be a detrimental factor for virus clearance.
BibTeX
@inproceedings{zhang2020influencing,
  author = {Lina Zhang and Xiaoàn Yang and Xuan Li and Yifan Jia and Fang Huang and Ka Zhang and Qing‐Yu He},
  title = {{Influencing factors of virus duration and virus clearance in COVID-19 patients in Shenzhen: A retrospective study.}},
  booktitle = {Research Square},
  year = {2020},
  doi = {10.21203/rs.3.rs-30438/v1},
}
Figure